Recent Finacing
Recent Raise
Ansun BioPharma is a clinical-stage biopharmaceutical company developing DAS181, a broad-spectrum antiviral for respiratory viruses (influenza, parainfluenza, metapneumovirus), advancing a planned Phase 3 parainfluenza trial with FDA interactions.
